For this purpose, we directly injected a high-affinity anti-AQP4 monoclonal antibody, E5415A, which has been shown to induce very severe NMO-like pathology when peripherally injected into rats with pre-existing EAE [17, 18]. Here, AQP4 is linked to neuromyelitis optica.